At Nuvothera, Rx Derma Veterans Develop OTCs For Serious Skin Conditions
Executive Summary
Firm launched Prosoria in 2018 as a four-product topical line for inflammatory autoimmune disease psoriasis containing salicylic acid 3% combined with turmeric and other botanicals. CEO Arthur Clapp says firm will launch turmeric supplements and plans adding products for acne, eczema, warts, nail fungus and rosacea.
You may also be interested in...
Differin Gel Enters Changed Marketplace Since Last OTC Acne Drug Approval
Galderma Labs' adapalene gel is pending launch as first OTC acne ingredient approved through an NDA and first new acne ingredient available OTC in 20 years, but company must play in a digitally-oriented marketplace.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.